Download Heart Disease Patients will be considered to be in the terminal stage

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Seven Countries Study wikipedia , lookup

Management of multiple sclerosis wikipedia , lookup

List of medical mnemonics wikipedia , lookup

Transcript
Heart Disease Patients will be considered to be in the terminal stage of heart disease (life expectancy of six
months or less) if they meet the following criteria. (1 and 2 should be present. Factors from 3 will add
supporting documentation.)
1. At the time of initial certification or recertification for hospice, the patient is or has been already optimally
treated for heart disease, or are patients who are either not candidates for surgical procedures or who decline
those procedures. (Optimally treated means that patients who are not on vasodilators have a medical reason
for refusing these drugs, e.g., hypotension or renal disease.)
2. Patients with congestive heart failure or angina should meet the criteria for the New York Heart
Association (NYHA) Class IV. (Class IV patients with heart disease have an inability to carry on any
physical activity. Symptoms of heart failure or of the anginal syndrome may be present even at rest. If any
physical activity is undertaken, discomfort is increased.) Significant congestive heart failure may be
documented by an ejection fraction of less than or equal to 20%, but is not required if not already available.
3. Documentation of the following factors will support but is not required to establish eligibility for hospice
care:
a. Treatment-resistant symptomatic supraventricular or ventricular arrhythmias;
b. History of cardiac arrest or resuscitation;
c. History of unexplained syncope;
d. Brain embolism of cardiac origin;
e. Concomitant HIV disease.
Local Coverage Determination (LCD) for Hospice—Determining Terminal Status
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult:
Executive Summary A Report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and
Management of Heart Failure) Stages of Heart Failure (HF)
Stage A Patients at high risk of developing HF because of the presence of conditions that are strongly
associated with the development of HF. Such patients have no identified structural or functional
abnormalities of the pericardium, myocardium, or cardiac valves and have never shown signs or symptoms of
HF. Example: Systemic hypertension; coronary artery disease; diabetes mellitus; history of cardiotoxic drug
therapy or alcohol abuse; personal history of rheumatic fever; family history of cardiomyopathy.
Stage B Patients who have developed structural heart disease that is strongly associated with the
development of HF but who have never show signs or symptoms of HF. Example: Left ventricular
hypertrophy or fibrosis; left ventricular dilatation or hypocontractility; asymptomatic valvular heart disease;
previous myocardial infarction.
Stage C Patients who have current or prior symptoms of HF associated with underlying structural heart
disease. Example: Dyspnea or fatigue due to left ventricular systolic dysfunction; asymptomatic patients who
are undergoing treatment for prior symptoms of HF.
Stage D Patients with advanced structural heart disease and marked symptoms of HF at rest despite maximal
medical therapy and who require specialized interventions. Example: Patients who are frequently hospitalized
for HF or cannot be safely discharged from the hospital; patients in the hospital awaiting heart
transplantation; patients at home receiving continuous intravenous support for symptom relief or being
supported with a mechanical circulatory assist device; patients in a hospice setting for management of HF.
Local Coverage Determination (LCD) for Hospice—Determining Terminal Status
NYHA Functional Classification for Congestive Heart Failure The New York Heart Association (NYHA)
Functional Classification provides a simple way of classifying heart disease (originally cardiac failure). It
places patients in one of four categories, based on how much they are limited during physical activity:
Class I: patients with no limitation of activities; they suffer no symptoms from ordinary activities.
Class II: patients with slight, mild limitation of activity; they are comfortable with rest or with mild exertion.
Class III: patients with marked limitation of activity; they are comfortable only at rest.
Class IV: patients who should be at complete rest, confined to bed or chair; any physical activity brings on
discomfort and symptoms occur at rest.
LCD for Hospice - Determining Terminal Status
(L25678)
Contractor Information
Contractor Name
National Government Services, Inc.
www.ngsmedicare.com